These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17609924)

  • 41. Outcomes after radical prostatectomy for patients with clinical stages T1-T2 prostate cancer with pathologically positive lymph nodes in the prostate-specific antigen era.
    Dorin RP; Lieskovsky G; Fairey AS; Cai J; Daneshmand S
    Urol Oncol; 2013 Nov; 31(8):1441-7. PubMed ID: 22516714
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Obesity and risk of biochemical progression following radical prostatectomy at a tertiary care referral center.
    Freedland SJ; Grubb KA; Yiu SK; Humphreys EB; Nielsen ME; Mangold LA; Isaacs WB; Partin AW
    J Urol; 2005 Sep; 174(3):919-22. PubMed ID: 16093988
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Value of lymphadenectomy for limited nodal recurrence of prostate cancer after local therapy with curative intent].
    Wolff I; Grimm MO; Wirth M
    Urologe A; 2008 Nov; 47(11):1436-40. PubMed ID: 18813903
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A Solitary PSA-Negative Late Metastasis of Prostate Cancer on the Penis].
    Degener S; Schraa S; Roth S; Gödde D; Mathers MJ
    Aktuelle Urol; 2015 Mar; 46(2):148-50. PubMed ID: 25789783
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic challenges of clonal heterogeneity in prostate cancer.
    Haffner MC; De Marzo AM; Yegnasubramanian S; Epstein JI; Carter HB
    J Clin Oncol; 2015 Mar; 33(7):e38-40. PubMed ID: 24638011
    [No Abstract]   [Full Text] [Related]  

  • 46. Surgical treatment of high-risk prostate cancer.
    Soares R; Eden CG
    Minerva Urol Nefrol; 2015 Mar; 67(1):33-46. PubMed ID: 25358908
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Return of serum prostate specific antigen to undetectable level following removal of solitary lymph node metastasis.
    Katz EE; Harding JN; Brendler C
    J Urol; 2002 Dec; 168(6):2546. PubMed ID: 12441968
    [No Abstract]   [Full Text] [Related]  

  • 48. [Clinico-pathologic correlation in patients undergoing surgical staging and radical prostatectomy for prostatic cancer].
    Isa Kroon WA; De Castro Barbosa F; Abad Vivas-Perez JI; Robles García JE; Zudaire Bergera JJ; Berián Polo JM
    Actas Urol Esp; 1993 Feb; 17(2):122-5. PubMed ID: 7683170
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prostate-specific antigen level and risk of bone metastasis in Sudanese patients with prostate cancer.
    Khalid KE; Brair AI; Elhaj AM; Ali KE
    Saudi J Kidney Dis Transpl; 2011 Sep; 22(5):1041-3. PubMed ID: 21912047
    [No Abstract]   [Full Text] [Related]  

  • 50. Lymph node involvement in prostatic carcinoma.
    Varkarakis MJ; Murphy GP; Nelson CM; Chehval M; Moore RH; Flocks RH
    Urol Clin North Am; 1975 Feb; 2(1):197-212. PubMed ID: 1128748
    [No Abstract]   [Full Text] [Related]  

  • 51. Predictors of prostate-specific antigen biochemical recurrence in patients undergoing primary whole-gland prostate cryoablation.
    Liu YY; Chiang PH; Chuang YC; Lee WC; Cheng YT; Wang HJ
    Ann Surg Oncol; 2015 May; 22(5):1612-7. PubMed ID: 25287436
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum levels of PSA, ALP, ICTP, and BSP in prostate cancer patients and the significance of ROC curve in the diagnosis of prostate cancer bone metastases.
    Wei RJ; Li TY; Yang XC; Jia N; Yang XL; Song HB
    Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323113
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Elevated serum matrix metalloproteinase 7 levels predict poor prognosis after radical prostatectomy.
    Szarvas T; Becker M; Vom Dorp F; Meschede J; Scherag A; Bánkfalvi A; Reis H; Schmid KW; Romics I; Rübben H; Ergün S
    Int J Cancer; 2011 Mar; 128(6):1486-92. PubMed ID: 20473942
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Measurement of skeletal alkaline phosphatase in prostatic carcinoma. Preliminary report].
    Casetta G; Gamba P; Piana P; Pecchio F; Tizzani A
    Minerva Urol Nefrol; 1995 Mar; 47(1):9-12. PubMed ID: 7570264
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is radiotherapy useful in node-positive prostate cancer patients after radical prostatectomy?
    Van Poppel H
    Eur Urol; 2009 May; 55(5):1012-3. PubMed ID: 19261377
    [No Abstract]   [Full Text] [Related]  

  • 56. Re: Adverse Pathology and Undetectable Ultrasensitive Prostate-Specific Antigen after Radical Prostatectomy: Is Adjuvant Radiation Warranted?
    Taneja SS
    J Urol; 2015 Dec; 194(6):1631-2. PubMed ID: 26582665
    [No Abstract]   [Full Text] [Related]  

  • 57. Metastatic prostate cancer: assessment of response to systemic therapy.
    Dreicer R
    Semin Urol Oncol; 1997 Feb; 15(1):28-32. PubMed ID: 9050137
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical trials referral resource. Prostate cancer.
    Cheson BD; Kaplan RS; Phillips PH
    Oncology (Williston Park); 1994 Dec; 8(12):35-6. PubMed ID: 7534101
    [No Abstract]   [Full Text] [Related]  

  • 59. [The role of surgery in locally advanced prostate cancer].
    Palisaar RJ; Noldus J
    Urologe A; 2008 Nov; 47(11):1417-23. PubMed ID: 18820896
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detailed analysis of patients with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institutional study.
    Kim IY; Modi PK; Sadimin E; Ha YS; Kim JH; Skarecky D; Cha DY; Wambi CO; Ou YC; Yuh B; Park S; Llukani E; Albala DM; Wilson T; Ahlering T; Badani K; Ahn H; Lee DI; May M; Kim WJ; Lee DH
    J Urol; 2013 Aug; 190(2):527-34. PubMed ID: 23485503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.